Kalvara, Co-Owned by Miguel, Increases North American Footprint with West Coast Rollout of Cannabis Beverage Featuring Vessl™ Infusion Technology
LOS ANGELES–(BUSINESS WIRE)–Kalvara, the first cannabis beverage with in-the-cap infusion technology and sonic emulsification, today announced California is joining its growing international and domestic distribution. Grammy award winner Miguel is the co-founder, owner and Chief Creative Director of Kalvara, and is proud to finally debut Kalvara in his home state.
“Kalvara is a game changer,” said Miguel. “I can enjoy a fast and consistent lift wherever I am.”
Known for the patented Vessl™ closure—an innovative nitrogen-powered cannabis liquid delivery device—Kalvara provides a precise, consistent dose of fast-acting cannabinoids. There is no need to measure, mix, shake or guess. There is no button to push.
The multisensory experience of twisting the cap, hearing the release of the pressurized nitrogen, seeing the colorful THC liquid rush into the reusable bottle and tasting the naturally flavored beverage is unique in the industry and yet reminiscent of making oneself a cocktail. The rapid onset of the precise dose of THC is an ideal alcohol replacement for those looking for an alternative.
Each Kalvara variety comes in a 100mg five-pack: Citrus Twist is sweetened with exotic monk fruit; Berry Chill comes with an added 10mg CBD for relaxation; and Tropical Inspire adds an energy-boosting component. Kalvara is delicious on its own over ice or with a mixer.
Unlike cannabis drinks that are packaged in clumsy cans or bottles, Kalvara’s compact profile is easily integrated into retail spaces, and reduces waste with its reusable 3-ounce bottle.
The nanotechnology of the pressurized Vessl™ closure keeps the highly bioavailable cannabis oil fresh at ambient temperatures for an increased shelf life; the exceptional taste, aroma and color will not fade or oxidize. The drink itself is calorie-free and does not contain any sugar or preservatives.
Kalvara is available at licensed retailers in California, Nevada, New Mexico, Oklahoma, and Ontario, with other states and Canadian provinces coming soon. To learn more, visit Kalvara.com.
About Kalvara
Kalvara was born from a belief that enjoying the euphoric effects of cannabis could be easier, cleaner, and more consistent. Our aim was to create a smoke-free, no-guesswork alternative to other cannabis consumables. With our background in the beverage business, we developed an all-natural cannabis-infused drink that delivers a fast-acting and precise dose of THC every time. Through a rigorous process of testing and trials, plus the benefits provided by the patented technology of the Vessl™ closure and delivery system, we created Kalvara. Formulated for high bioavailability and rapid onset, we believe that Kalvara is the cannabis drink the world has been waiting for. Kalvara is a technology company with a packaging solution. For more information, please visit kalvara.com and check out Kalvara on Instagram @drinkkalvara.
About Miguel
Over the last decade, Miguel has established himself as an artist who is unafraid to follow his creative impulses to artistic greatness. His Grammy-winning “Adorn” was RIAA certified 2x Platinum and is just one of his 12 songs to hit the Billboard Hot 100.
As the recipient of 10 Grammy nominations, it’s no surprise Miguel’s last two albums debuted at #1 on Billboard’s R&B Albums Chart. In 2015, his second studio album “Wildheart” debuted at #2 on Billboard’s top 200 albums. In 2017, this was then followed up by his third studio album “War & Leisure,” which was released to further acclaim. Miguel’s latest release is the EP “Art Dealer Chic 4” (April 2021).
Boasting a resume full of solo hits, as well as collaborations with Mariah Carey, Alicia Keys, Usher, J. Cole, Travis Scott, and A$AP Rocky, among others, Miguel has proven himself to be one of R&B’s most sonic visionaries.
Follow Miguel on Instagram: @Miguel
Contacts
Media Contact:
Tatianna Apodaca
949-466-8607
[email protected]
Specific questions regarding Kalvara sales / Vessl™ closure:
Jeremy Taylor
808-227-0151
[email protected]
_(1).jpg "Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting"){kind=logo}
